Logo image of APM

APTORUM GROUP LTD-CLASS A (APM) Stock Fundamental Analysis

NASDAQ:APM - Nasdaq - KYG6096M1226 - Common Stock - Currency: USD

1.7  +0.09 (+5.59%)

Fundamental Rating

1

Taking everything into account, APM scores 1 out of 10 in our fundamental rating. APM was compared to 556 industry peers in the Biotechnology industry. APM has a bad profitability rating. Also its financial health evaluation is rather negative. APM has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year APM has reported negative net income.
APM had a negative operating cash flow in the past year.
In the past 5 years APM reported 4 times negative net income.
APM had a negative operating cash flow in each of the past 5 years.
APM Yearly Net Income VS EBIT VS OCF VS FCFAPM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

The Return On Assets of APM (-26.46%) is better than 71.04% of its industry peers.
APM has a Return On Equity of -20.19%. This is amongst the best in the industry. APM outperforms 85.43% of its industry peers.
Industry RankSector Rank
ROA -26.46%
ROE -20.19%
ROIC N/A
ROA(3y)-29.03%
ROA(5y)-37.43%
ROE(3y)-31.31%
ROE(5y)-36.99%
ROIC(3y)N/A
ROIC(5y)N/A
APM Yearly ROA, ROE, ROICAPM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

APM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
APM Yearly Profit, Operating, Gross MarginsAPM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

1

2. Health

2.1 Basic Checks

APM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for APM has been increased compared to 1 year ago.
The number of shares outstanding for APM has been reduced compared to 5 years ago.
The debt/assets ratio for APM is higher compared to a year ago.
APM Yearly Shares OutstandingAPM Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
APM Yearly Total Debt VS Total AssetsAPM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -8.67, we must say that APM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of APM (-8.67) is worse than 70.68% of its industry peers.
APM has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
APM has a Debt to Equity ratio (0.00) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -8.67
ROIC/WACCN/A
WACC7.53%
APM Yearly LT Debt VS Equity VS FCFAPM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 0.22 indicates that APM may have some problems paying its short term obligations.
With a Current ratio value of 0.22, APM is not doing good in the industry: 94.42% of the companies in the same industry are doing better.
APM has a Quick Ratio of 0.22. This is a bad value and indicates that APM is not financially healthy enough and could expect problems in meeting its short term obligations.
APM has a Quick ratio of 0.22. This is amonst the worse of the industry: APM underperforms 94.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
APM Yearly Current Assets VS Current LiabilitesAPM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

APM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.79%, which is quite good.
Looking at the last year, APM shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)13.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-156.89%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
Based on estimates for the next years, APM will show a very negative growth in Revenue. The Revenue will decrease by -16.88% on average per year.
EPS Next Y8528.57%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-78.44%
Revenue Next 2Y-60.2%
Revenue Next 3Y-38.21%
Revenue Next 5Y-16.88%

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
APM Yearly Revenue VS EstimatesAPM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
APM Yearly EPS VS EstimatesAPM Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

APM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 0.03, the valuation of APM can be described as very cheap.
Based on the Price/Forward Earnings ratio, APM is valued cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.71, APM is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.03
APM Price Earnings VS Forward Price EarningsAPM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
APM Per share dataAPM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

APM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

APTORUM GROUP LTD-CLASS A

NASDAQ:APM (7/23/2025, 10:19:06 AM)

1.7

+0.09 (+5.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)12-18 2025-12-18
Inst Owners1.76%
Inst Owner ChangeN/A
Ins Owners2.57%
Ins Owner ChangeN/A
Market Cap12.14M
Analysts80
Price TargetN/A
Short Float %0.77%
Short Ratio0.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.03
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.57
EV/EBITDA N/A
EPS(TTM)-0.79
EYN/A
EPS(NY)59.59
Fwd EY3505.29%
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS0
BVpS2.96
TBVpS2.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.46%
ROE -20.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-29.03%
ROA(5y)-37.43%
ROE(3y)-31.31%
ROE(5y)-36.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z -8.67
F-Score2
WACC7.53%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-156.89%
EPS Next Y8528.57%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-78.44%
Revenue Next 2Y-60.2%
Revenue Next 3Y-38.21%
Revenue Next 5Y-16.88%
EBIT growth 1Y63.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-97.69%
EBIT Next 3Y-54.02%
EBIT Next 5Y-27.84%
FCF growth 1Y84.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y84.6%
OCF growth 3YN/A
OCF growth 5YN/A